Publicacions en què col·labora amb David Bernardo Ordiz (10)

2022

  1. Differential Effects of Anti-TNFα and Anti-α4β7 Drugs on Circulating Dendritic Cells Migratory Capacity in Inflammatory Bowel Disease

    Biomedicines, Vol. 10, Núm. 8

2021

  1. Lunasin Peptide is a Modulator of the Immune Response in the Human Gastrointestinal Tract

    Molecular Nutrition and Food Research, Vol. 65, Núm. 12

  2. Profiling of Human Circulating Dendritic Cells and Monocyte Subsets Discriminates between Type and Mucosal Status in Patients with Inflammatory Bowel Disease

    Inflammatory Bowel Diseases, Vol. 27, Núm. 2, pp. 268-274

2020

  1. A quick flow cytometry protocol to assess Helicobacter pylori viability

    Journal of Microbiological Methods, Vol. 177

  2. Serum adipokines as non-invasive biomarkers in Crohn’s disease

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

    Therapeutic Advances in Gastroenterology, Vol. 12

  2. Immunomodulatory effect of gut microbiota-derived bioactive peptides on human immune system from healthy controls and patients with inflammatory bowel disease

    Nutrients, Vol. 11, Núm. 11

  3. Peptides encrypted in the human intestinal microbial-exoproteome as novel biomarkers and immunomodulatory compounds in the gastrointestinal tract

    Journal of Functional Foods, Vol. 52, pp. 459-468

  4. Role of food proteins and bioactive peptides in inflammatory bowel disease

    Trends in Food Science and Technology, Vol. 88, pp. 194-206

2018

  1. Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c-CCR2-CX3CR1- counterparts, are expanded in inflammatory bowel disease article

    Mucosal Immunology, Vol. 11, Núm. 4, pp. 1114-1126